US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

36.30

+0.51001.42%

Post-market: 36.470.1700+0.47%18:40 EDT

Volume:17.89K

Turnover:646.73K

Market Cap:98.74M

PE:- -

High:36.45

Open:35.93

Low:35.75

Close:35.79

52wk High:36.84

52wk Low:23.42

Shares:2.72M

Float Shares:2.72M

Volume Ratio:0.59

T/O Rate:0.66%

Dividend:0.26

Dividend Rate:0.71%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

AstraZeneca-Amgen Asthma Drug Succeeds in Late-Stage Oesophagus Disease Trial

Amgen - Tezspire Safety Profile Consistent with Approved Indications

THOMSON REUTERS

Tezspire® Demonstrates Positive Phase 3 Results in Eosinophilic Esophagitis Across Both Co-Primary and All Key Secondary Endpoints

THOMSON REUTERS

Innovative Drug Sector Resurgence: Fund Manager Breaks Down the Rally's Driving Forces

Hong Kong Stock Alert | IMMUNEONCO-B (01541) Surges Nearly 12% as Robust Cash Reserves and Major Clinical Milestones Drive Sentiment

Moderna Inc. Stock Falls 5.8%, Underperforms Peers

Gilead Sciences Updates Financial Calendar with Investor Conference Presentations

Vertex to Present at Wells Fargo Healthcare Investor Conference Fireside Chat

Unlocking Pipeline Value: Discovering A-Share Innovative Drug Investment Opportunities Through a DCF Lens

MICOT Pharma's Stroke Drug Completes Mid-Stage Trial in China

China's Top Innovative Drugmaker Sees Profits Surge Sixfold, Market Cap Reaches 430 Billion Yuan

IMMUNEONCO-B Reports Interim Results with RMB 25.4 Million Revenue and Key Clinical Trial Milestones

Financial Heavyweights Drive Gains as Multiple Sectors Rally on Policy Support and Solid Earnings

BOAN BIOTECH (06955) Submits IND for BA2201 (TL1A/IL-23) as CDE Accepts Clinical Trial Application

Jiangsu Unveils Plan to Encourage Inclusion of Innovative Drugs in Commercial Health Insurance and Mutual Aid Coverage

Sino Biopharmaceutical Stock Climbs 2.1% in Hong Kong, Outperforms Competitors

Fosun Pharma's H1 Report: Innovative Drug Revenue Surges 13.8% as Global Expansion Spans Three Continents

Hong Kong Biotech Sector Surges Again as Innovative Drug Stocks Lead Gains, INNOVENT BIO Hits Record High

Circio and Full Circles join forces on non-viral in vivo cell therapy platform

SIHUAN PHARM Posts 119% Profit Surge in Interim Results, Reinforcing Dual-Engine Strategy

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/IBBQ/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":36.3,"timestamp":1788379200000,"preClose":35.79,"halted":0,"volume":17889,"hourTrading":{"tag":"盘后","latestPrice":36.47,"preClose":36.3,"latestTime":"18:40 EDT","volume":170,"amount":6173.00056,"timestamp":1788388831406,"change":0.17,"changeRate":0.004683,"amplitude":0.004683},"delay":0,"changeRate":0.014249790444258118,"floatShares":2720001,"shares":2720001,"eps":0,"marketStatus":"Post-Mkt","change":0.51,"latestTime":"09-02 19:09:38 EDT","open":35.93,"high":36.45,"low":35.7472,"amount":646726.473243,"amplitude":0.019637,"askPrice":54.34,"askSize":200,"bidPrice":34,"bidSize":1,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788393600000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":35.79,"sharesOutstanding":2520001,"nav":35.43802,"aum":96391449.83802,"dividendRate":0.007052,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":35.79,"preClose":35.79,"latestTime":"07:00 EDT","volume":100,"amount":3579.2799999999997,"timestamp":1788346812804,"change":0,"changeRate":0,"amplitude":0.007823},"postHourTrading":{"tag":"盘后","latestPrice":36.47,"preClose":36.3,"latestTime":"18:40 EDT","volume":170,"amount":6173.00056,"timestamp":1788388831406,"change":0.17,"changeRate":0.004683,"amplitude":0.004683},"volumeRatio":0.585304,"impliedVol":0.1027,"impliedVolPercentile":0.4246},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":2720001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.585304,"shares":2720001,"dividePrice":0.256,"high":36.45,"amplitude":0.019637,"preClose":35.79,"low":35.7472,"week52Low":23.42,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":36.3,"committee":-0.99005,"eps":0,"divideRate":0.007052,"volume":17889,"delay":0,"ttmEps":0,"open":35.93,"prevYearClose":28.3962,"prevWeekClose":35.47,"prevMonthClose":35.4742,"prevQuarterClose":32.66,"fiveDayClose":36.57,"twentyDayClose":32.93,"sixtyDayClose":28.77},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"IBBQ","amount":0.0287,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662514775","title":"AstraZeneca-Amgen Asthma Drug Succeeds in Late-Stage Oesophagus Disease Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662514775","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662514775?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:40","pubTimestamp":1787812818,"startTime":"0","endTime":"0","summary":"UPDATE 3-AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trialAug 27 (Reuters)-AstraZenecaAZN.Lsaid on Thursday its asthma drug Tezspire met the main goals of a late-stage tria","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL6N44O0DF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1051770623.HKD","IBB","03165","LU1481600234.SGD","BIB","LU0997586432.USD","LU1153584641.USD","LU1571399168.USD","LU0345777659.USD","LU0997586515.USD","LU1119994496.HKD","LU1880407132.USD","LU1003077747.HKD","IE00BFTCPJ56.SGD","LU0052756011.USD","LU0738911758.USD","LU1267930490.SGD","LU2237443382.USD","AZN.UK","LU0661504455.SGD","LU0823434583.USD","LU1170363599.USD","LU1829250122.USD","LU0432979614.USD","LU2293690082.USD","LU0575583348.USD","LU0047473722.EUR","PBE","LU2242652126.USD","BBH","LU0792757196.USD","BK4588","BK4599","TBXU","LU0887340254.USD","LU1974910355.USD","LU0077335932.USD","LU1057294990.SGD","LU0266013472.USD","LU0122379950.USD","PJP","LU0310799852.SGD","AMGN","SGXZ57979304.SGD","LU0640478417.SGD","LU2237443622.USD","LU3187612489.SGD","REGN","IBBQ","LU0972486137.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662778025","title":"Amgen - Tezspire Safety Profile Consistent with Approved Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2662778025","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662778025?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:00","pubTimestamp":1787810401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUA3XV48Z:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBBQ","LU1023059063.AUD","LU0868494617.USD","BBH","BK4599","LU2242646821.SGD","BK4585","BIB","IE00BJJMRZ35.SGD","LU2112291526.USD","LU0109394709.USD","LU2468319806.SGD","IE0002141913.USD","BK4588","AMGN","LU2242652126.USD","LU0889565916.HKD","LU1057294990.SGD","IE0009355771.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4533","LU1571399168.USD","PBE","BK4581","BK4534","LU0320765992.SGD","IE00BFTCPJ56.SGD","PJP","SG9999001440.SGD","IE00BJT1NW94.SGD","LU1983299246.USD","IBB","LU0122379950.USD","BK4566","LU2089984988.USD","LU0289739699.SGD","LU0058720904.USD","TBXU","LU1061106388.HKD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662728778","title":"Tezspire® Demonstrates Positive Phase 3 Results in Eosinophilic Esophagitis Across Both Co-Primary and All Key Secondary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2662728778","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662728778?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:00","pubTimestamp":1787810401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUA3XV48Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0289739699.SGD","PJP","BBH","LU0868494617.USD","BK4139","LU1983299246.USD","LU2112291526.USD","BK4534","BK4588","IE00BFTCPJ56.SGD","LU0320765992.SGD","BK4533","LU2242652126.USD","IE00BJJMRZ35.SGD","LU1061106388.HKD","IBB","LU1571399168.USD","LU2242646821.SGD","LU0058720904.USD","SG9999001440.SGD","PBE","LU0889565916.HKD","LU1023059063.AUD","LU2089984988.USD","IBBQ","TBXU","LU0122379950.USD","IE00BJT1NW94.SGD","BIB","IE0002141913.USD","BK4585","AMGN","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4566","LU2468319806.SGD","LU1057294990.SGD","LU0109394709.USD","BK4599","BK4581","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153198003","title":"Innovative Drug Sector Resurgence: Fund Manager Breaks Down the Rally's Driving Forces","url":"https://stock-news.laohu8.com/highlight/detail?id=1153198003","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153198003?lang=en_us&edition=fundamental","pubTime":"2026-08-27 11:30","pubTimestamp":1787801432,"startTime":"0","endTime":"0","summary":"As interim earnings reports flood the market, the innovative drug sector has reignited investor enthusiasm, with several leading stocks surging post-results. On August 26, Innovent Biologics jumped...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","MEDX","BK1574","IBBQ","159992","520880","LNGR","06978","FLHK","159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187887739","title":"Hong Kong Stock Alert | IMMUNEONCO-B (01541) Surges Nearly 12% as Robust Cash Reserves and Major Clinical Milestones Drive Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1187887739","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187887739?lang=en_us&edition=fundamental","pubTime":"2026-08-27 11:00","pubTimestamp":1787799615,"startTime":"0","endTime":"0","summary":"Shares of IMMUNEONCO-B (01541) jumped nearly 12% during Tuesday trading, last up 10.41% at HK$4.085 with turnover reaching HK$3.429 million.The surge follows the company's interim results released on...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","IBBQ","BMED","BK1161","BK4585","VXUS","IBBJ","MDTX","PSYK","BK4588","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662440957","title":"Moderna Inc. Stock Falls 5.8%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662440957","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662440957?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:33","pubTimestamp":1787776380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slid 5.8% to $149.66 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.1% to 26,130.20 and Dow Jones Industrial Average falling 0.2% to 53,463.88.Moderna Inc. closed 15.3% short of its 52-week high of $176.66, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.1% to $270.00, Pfizer Inc. fell 0.9% to $28.30, and Gilead Sciences Inc. fell 0.46% to $148.09.Trading volume totaled 21.8 million, compared to the 50-day average of 16.1 million.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","BK4578","SG9999015978.USD","IBBQ","TMED","IE00B19Z3581.USD","GNOM","BK4533","BK4551","LU0320765992.SGD","LU1674673691.USD","LU2357627491.SGD","LU0058720904.USD","GILD","MEDI","MRNX","IDNA","IE00B7SZLL34.SGD","SG9999015952.SGD","LU1585245621.USD","BK4548","LU0122379950.USD","LU0861579265.USD","LU0965509101.SGD","BK4532","LGHT","IBB","LU0965508806.USD","LU0109394709.USD","LU1934455863.HKD","MRNY","LU1839511570.USD","LU2324357040.USD","LU1057294990.SGD","LU1674673428.USD","LU2087621335.USD","BMED","IE00BZ1G4Q59.USD","BK4585","IE0002270589.USD","LU1571399168.USD","BBH","WDNA","BIB","TBXU","BK4534","LU0965509283.SGD","MRNA","LU0234570918.USD","LU1037948541.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662417787","title":"Gilead Sciences Updates Financial Calendar with Investor Conference Presentations","url":"https://stock-news.laohu8.com/highlight/detail?id=2662417787","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662417787?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:05","pubTimestamp":1787774725,"startTime":"0","endTime":"0","summary":"Gilead Sciences updates financial calendar with investor conference presentationsGilead executives will present at the Wells Fargo Annual Healthcare Conference on September 9 at 11:00 a.m. ET.Presenta","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL8cjLQm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","LU0109394709.USD","LU1037948897.HKD","IBBQ","LU0861579265.USD","LU0889565916.HKD","LU1674673691.USD","LU1934455277.USD","LU1778281490.HKD","BK4568","LU0234570918.USD","LU1585245621.USD","LU2087621335.USD","LU0122379950.USD","IE00B19Z3581.USD","BK4585","BK4588","LU0823416689.USD","BIB","IE0002270589.USD","TBXU","MEDI","IE00B3T34201.USD","LU1430594728.SGD","IE00B7SZLL34.SGD","LU2112291526.USD","BK4583","BK4550","LU0965508806.USD","LU1674673428.USD","LU1057294990.SGD","LU0859254822.USD","LU2089984988.USD","LU0965509010.AUD","IE00BZ1G4Q59.USD","LU1023059063.AUD","SG9999015952.SGD","TMED","LU1571399168.USD","LU0965509283.SGD","BBH","IBB","LU1037948541.HKD","GILD","LU0882574055.USD","BMED","LU1066053197.SGD","IE00BKVL7J92.USD","LU0289739699.SGD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662741464","title":"Vertex to Present at Wells Fargo Healthcare Investor Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2662741464","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662741464?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:00","pubTimestamp":1787774425,"startTime":"0","endTime":"0","summary":"Vertex to present at Wells Fargo healthcare investor conference fireside chatVertex will join four investor conference fireside chats in September 2026, led by senior management.Wells Fargo 21st Annua","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL7VGD1d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBE","BK4533","LU1430594728.SGD","GNMX","SGXZ57979304.SGD","LU2462157665.USD","LU2089984988.USD","BK4139","LU1069344957.HKD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU1674673691.USD","LU1093756168.USD","IE00B4R5TH58.HKD","IE00B19Z9P08.USD","IE00B19Z3581.USD","LU0417517546.SGD","LU0432979614.USD","SG9999001176.USD","LU2362541513.USD","BBH","LU0256863811.USD","IE00B19Z3B42.SGD","IE00B894F039.SGD","LU0320765992.SGD","IBBQ","LU0109394709.USD","IBB","LU0289739699.SGD","LU0058720904.USD","LU2468319806.SGD","LU1674673428.USD","LU1778281490.HKD","BIB","BK4567","SG9999013999.USD","IE00B19Z9Z06.USD","LU0079474960.USD","VRTX","LU0234570918.USD","LU2362540622.SGD","LU1035775433.USD","TBXU","IDNA","LU2417539215.USD","IE0002141913.USD","IE00B2B36J28.USD","LU0889565916.HKD","LU2362541273.HKD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125221751","title":"Unlocking Pipeline Value: Discovering A-Share Innovative Drug Investment Opportunities Through a DCF Lens","url":"https://stock-news.laohu8.com/highlight/detail?id=1125221751","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125221751?lang=en_us&edition=fundamental","pubTime":"2026-08-26 23:20","pubTimestamp":1787757649,"startTime":"0","endTime":"0","summary":"The innovative drug industry is defined by its \"double ten\" characteristics—a research and development cycle of roughly a decade and an investment of about one billion US dollars per molecule. During...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","MEDX","IBBQ","159992","DCF","BK1574","06978","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114989011","title":"MICOT Pharma's Stroke Drug Completes Mid-Stage Trial in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1114989011","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114989011?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:42","pubTimestamp":1787755330,"startTime":"0","endTime":"0","summary":"MICOT PHARMA-B (02335) has announced the completion of a Phase II clinical trial for its self-developed candidate drug MT200605, designed to treat acute ischemic stroke (AIS).The trial demonstrated...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","BK1161","PSYK","02335","IBBJ","IBBQ","MDTX","AIS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142229559","title":"China's Top Innovative Drugmaker Sees Profits Surge Sixfold, Market Cap Reaches 430 Billion Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1142229559","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142229559?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:10","pubTimestamp":1787753427,"startTime":"0","endTime":"0","summary":"BeiGene Ltd (SH: 688235), trading at 279.00 yuan per share with a market capitalization of 430.298 billion yuan, released its semi-annual report for 2026 on August 26. The report reveals that the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","MEDX","BK1574","BK1161","IBBQ","LNGR","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152821983","title":"IMMUNEONCO-B Reports Interim Results with RMB 25.4 Million Revenue and Key Clinical Trial Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=1152821983","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152821983?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:56","pubTimestamp":1787752576,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) has released its interim results for the six months ended June 30, 2026, reporting revenue of RMB 25.424 million. Research and development expenses totaled RMB 155 million,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","MDTX","IBBJ","PSYK","BK1161","BMED","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143818871","title":"Financial Heavyweights Drive Gains as Multiple Sectors Rally on Policy Support and Solid Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=1143818871","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143818871?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:21","pubTimestamp":1787743279,"startTime":"0","endTime":"0","summary":"On Tuesday (August 26), all three major A-share indices closed higher, with advancing stocks outnumbering decliners across the market. Total turnover on the Shanghai, Shenzhen, and Beijing exchanges...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCE","IBBQ","BK1574","159992","512000","BK1161","LNGR","MEDX","06978","159876"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159273287","title":"BOAN BIOTECH (06955) Submits IND for BA2201 (TL1A/IL-23) as CDE Accepts Clinical Trial Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1159273287","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159273287?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:14","pubTimestamp":1787742861,"startTime":"0","endTime":"0","summary":"BOAN BIOTECH has announced that its investigational new drug (IND) application for BA2201 has been accepted for review by the Center for Drug Evaluation (CDE) of China's National Medical Products...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XME","IBBQ","MDTX","SGDM","SIL","LU1223082519.USD","BK4017","BMED","06955","LU1223082196.USD","LU1223083913.SGD","GDXJ","PSYK","IBBJ","CDE","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136653718","title":"Jiangsu Unveils Plan to Encourage Inclusion of Innovative Drugs in Commercial Health Insurance and Mutual Aid Coverage","url":"https://stock-news.laohu8.com/highlight/detail?id=1136653718","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136653718?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:11","pubTimestamp":1787739064,"startTime":"0","endTime":"0","summary":"On August 26, in a financial frontline update, Jiangsu Province issued the \"Three-Year Action Plan for Promoting High-Quality Development of the Biomedical Industry.\" The plan highlights the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","IBBQ","LNGR","159891","06978","BK4581","XLV","MEDX","BK4588","159992","LABU","XBI","BK1161","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662796495","title":"Sino Biopharmaceutical Stock Climbs 2.1% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662796495","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662796495?lang=en_us&edition=fundamental","pubTime":"2026-08-26 16:32","pubTimestamp":1787733120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rallied 2.1% to 5.74 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.6% to 25652.97.This was the stock's second consecutive day of gains.Sino Biopharmaceutical Ltd. closed 37% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 1.2% and Amgen Inc. remained unchanged.Trading volume totaled 180.5 million shares, compared to the 50-day average of 101.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","IE00BJJMRZ35.SGD","LU1061106388.HKD","BK4534","BK1191","BK4581","IBB","LU0289739699.SGD","BBH","LU0122379950.USD","HK0000165453.HKD","IE00BZ08YT58.USD","LU2089984988.USD","LU1571399168.USD","PJP","LU1023059063.AUD","LU0320765992.SGD","AMGN","01177","BK4599","BK1515","IE0009355771.USD","PBE","LU1983299246.USD","BIB","LU2112291526.USD","BK4588","IE00BJT1NW94.SGD","TBXU","LU0889565916.HKD","IE00BZ08YR35.GBP","LU2468319806.SGD","LU0058720904.USD","BK4139","BK4585","BK4566","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU2242652126.USD","IBBQ","BK1589","LU1057294990.SGD","SG9999001440.SGD","BK4533","BK1521","LU0868494617.USD","IE0002141913.USD","IE00B4R5TH58.HKD","LU0109394709.USD","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171725498","title":"Fosun Pharma's H1 Report: Innovative Drug Revenue Surges 13.8% as Global Expansion Spans Three Continents","url":"https://stock-news.laohu8.com/highlight/detail?id=1171725498","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171725498?lang=en_us&edition=fundamental","pubTime":"2026-08-26 15:00","pubTimestamp":1787727650,"startTime":"0","endTime":"0","summary":"On August 25, 2026, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SH; 02196.HK) unveiled its first-half scorecard. The interim results, disclosed on the evening of August 25, show operating...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","BK0196","IBBQ","BK1593","BK1574","BK1191","BK0175","BK1161","BK0028","LNGR","BK0187","02196","BK0188","BK0239","600196","06978","BK0060","159992","BK0183","MEDX","BK1515","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149059268","title":"Hong Kong Biotech Sector Surges Again as Innovative Drug Stocks Lead Gains, INNOVENT BIO Hits Record High","url":"https://stock-news.laohu8.com/highlight/detail?id=1149059268","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149059268?lang=en_us&edition=fundamental","pubTime":"2026-08-26 14:02","pubTimestamp":1787724134,"startTime":"0","endTime":"0","summary":"Hong Kong healthcare stocks continued their upward momentum on August 26, with innovative drug developers taking over the leadership baton from the CXO sector. Cansino Biologics Inc. soared more than...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","BK0239","159992","MEDX","HK0000165453.HKD","LU1969619763.USD","LU1188198961.HKD","BK1589","LU0326950275.SGD","IBBQ","LU0463099449.HKD","LU2097828474.EUR","LU2242644610.SGD","688185","LU2097828631.EUR","BK1583","FLHK","BK1161","KURE","159646","LU0502904849.HKD","LU2328871848.SGD","BK1574","LU0244354667.USD","LU2097828805.USD","LU2097828714.EUR","LU2488822045.USD","LU2097828557.USD","01801","LU0455707207.USD","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662760351","title":"Circio and Full Circles join forces on non-viral in vivo cell therapy platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2662760351","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662760351?lang=en_us&edition=fundamental","pubTime":"2026-08-26 13:43","pubTimestamp":1787723005,"startTime":"0","endTime":"0","summary":"Targovax ASA ( ($GB:0RIS) ) just unveiled an announcement. Circio Holding ASA and Full Circles Therapeutics have entered a research collaboration t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/circio-and-full-circles-join-forces-on-non-viral-in-vivo-cell-therapy-platform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/circio-and-full-circles-join-forces-on-non-viral-in-vivo-cell-therapy-platform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","BK4588","BK4585","FBT","CNCR","IBBQ","IBB","TBXU","LFSC","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191993997","title":"SIHUAN PHARM Posts 119% Profit Surge in Interim Results, Reinforcing Dual-Engine Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=1191993997","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191993997?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:36","pubTimestamp":1787718981,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) has reported its interim results for the six months ended June 30, 2026, showcasing a substantial jump in profitability. The group recorded a total revenue of RMB 1.161 billion,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","BK1161","00460","BK1515","06978","BK1593","BK1600","BK1191","BK1574","IBBQ","159992","MEDX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}